Pricing Log in Create free account

Crescent Biopharma, Inc. (CBIO) vs REGENXBIO Inc. (RGNX)

Crescent Biopharma, Inc. and REGENXBIO Inc. are both Biotechnology companies. Crescent Biopharma, Inc. and REGENXBIO Inc. are of similar size ($472.7M and $463.6M). REGENXBIO Inc. grew revenue faster over the last twelve months: 12.0% against −45.1%. Crescent Biopharma, Inc. has the higher net margin (0.00% vs −112.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Crescent Biopharma, Inc. leads on 10 and REGENXBIO Inc. on 6.

Valuation

Metric CBIO RGNX Biotechnology median
P/E n/m n/m 8.50
P/S 296.75 2.10 9.71
P/B 2.27 5.10 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 186.66 1.53 9.21
Earnings yield (56.76%) (54.69%) (33.15%)
Free cash flow yield (19.88%) (68.21%) (25.50%)

Profitability

Metric CBIO RGNX Biotechnology median
Gross margin 19.72% 86.38% 65.16%
Operating margin 0.00% (94.08%) 0.00%
Net margin 0.00% (112.58%) 0.00%
Free cash flow margin 0.00% (143.09%) 0.00%
Return on equity (112.14%) (137.63%) (56.36%)
Return on assets (97.08%) (40.60%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CBIO RGNX Biotechnology median
Revenue growth (TTM) (45.09%) 12.00% 6.02%
EPS growth (last fiscal year) 44.97% 18.08% 30.26%
Revenue growth, 5-year CAGR 257.77% 1.97% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CBIO RGNX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.66 2.86 4.72
Net debt to EBITDA 1.40 1.58 0.96

Dividend

Metric CBIO RGNX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CBIO RGNX Biotechnology median
Market cap 463.56m 472.65m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack